149 related articles for article (PubMed ID: 17802789)
1. [Recovery of peripheral blood lymphocytes in patients with hematological diseases after allogenic non-relative transplantation of hemopoietic stem cells].
Vavilov VN; Zander AR; Afanas'iev BV
Ter Arkh; 2007; 79(7):44-7. PubMed ID: 17802789
[TBL] [Abstract][Full Text] [Related]
2. [Allogenic transplantation of hemopoietic stem cells in low-intensity regimes in patients with hematological malignancies].
Demidova IA; Parovichnikova EN; Kut'ina RM; Poreshina LP; Shpakova AP; Ol'shanskaia IuV; Misiurin AV; Savchenko VG
Ter Arkh; 2007; 79(7):48-52. PubMed ID: 17802790
[TBL] [Abstract][Full Text] [Related]
3. [The experience in non-relative allogenic transplantation of stem hemopoietic cells in the Clinic of Bone Marrow Transplantation at I.P. Pavlov St-Petersburg Medical Academy].
Afanas'iev BV; Zubarovskaia LS; Semenov EV; Ivanova NE; Alianskiĭ AL; Morozova EV; Mikhaĭlova NB; Darskaia EI; Estrina MA; Golovacheva AA; Babenko EV; Bondarenko SN; Ganapiev AA; Bogomol'nyĭ MP
Ter Arkh; 2007; 79(7):36-43. PubMed ID: 17802788
[TBL] [Abstract][Full Text] [Related]
4. [Transplantations of allogenic and autologous hemopoietic stem cells in acute leukemia (results of 20-year experience)].
Savchenko VG; Liubimova LS; Parovichnikova EN; Mendeleeva LP; Mamotiuk KS; Demidova IA; Gribanova EO; Gal'tseva IV; Pokrovskaia OS; Kuz'mina LA; Zhelnova EI; Kliasova GA; Glasko EN; Kaplanskaia IB; Poreshina LP; Kut'ina RM; Shpakova AP; Shtareva EM; Varlamova SV; Kalinin NN
Ter Arkh; 2007; 79(7):30-5. PubMed ID: 17802787
[TBL] [Abstract][Full Text] [Related]
5. Long-term persistent lymphopenia in hematopoietic stem cell donors after donation for donor lymphocyte infusion.
Nicolini FE; Wattel E; Michallet AS; Bourgeot JP; Tremisi JP; Hequet O; Michallet M
Exp Hematol; 2004 Nov; 32(11):1033-9. PubMed ID: 15539080
[TBL] [Abstract][Full Text] [Related]
6. Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse.
Yakoub-Agha I; Saule P; Magro L; Cracco P; Duhamel A; Coiteux V; Bruno B; Dufossé F; Jouet JP; Dessaint JP; Labalette M
Biol Blood Marrow Transplant; 2009 Apr; 15(4):496-504. PubMed ID: 19285638
[TBL] [Abstract][Full Text] [Related]
7. High CD8+ lymphocyte dose in the autograft predicts early absolute lymphocyte count recovery after peripheral hematopoietic stem cell transplantation.
Atta EH; de Azevedo AM; Maiolino A; Coelho CJ; Sarcinelli SM; de Alvarenga Máximo C; Marra VL
Am J Hematol; 2009 Jan; 84(1):21-8. PubMed ID: 19006229
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
[TBL] [Abstract][Full Text] [Related]
9. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
Yoon DH; Sohn BS; Jang G; Kim EK; Kang BW; Kim C; Kim JE; Kim S; Lee DH; Lee JS; Park SJ; Park CJ; Huh J; Suh C
Transfusion; 2009 Sep; 49(9):1890-900. PubMed ID: 19453991
[TBL] [Abstract][Full Text] [Related]
10. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.
Kobayashi K; Maeda Y; Hara Y; Nishie-Kataoka M; Nishimori H; Sugiyama H; Namba N; Kubonishi S; Niiya M; Shinagawa K; Ikeda K; Tanimoto M
Anticancer Res; 2009 May; 29(5):1763-70. PubMed ID: 19443401
[TBL] [Abstract][Full Text] [Related]
13. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
[TBL] [Abstract][Full Text] [Related]
14. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
15. Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor.
Martín-Donaire T; Rico M; Bautista G; Gonzalo-Daganzo R; Regidor C; Ojeda E; Sanjuán I; Forés R; Ruiz E; Krsnik I; Navarro B; Gil S; Magro E; Millán I; Sánchez R; Pérez-Sanz N; Panadero N; García-Marco JA; Cabrera R; Fernández MN
Bone Marrow Transplant; 2009 Aug; 44(4):213-25. PubMed ID: 19252533
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Michallet M; Le QH; Mohty M; Prébet T; Nicolini F; Boiron JM; Esperou H; Attal M; Milpied N; Lioure B; Bordigoni P; Yakoub-Agha I; Bourhis JH; Rio B; Deconinck E; Renaud M; Chir Z; Blaise D
Exp Hematol; 2008 May; 36(5):535-44. PubMed ID: 18346838
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome.
Talarn C; Urbano-Ispizua A; Martino R; Pérez-Simón JA; Batlle M; Herrera C; Granell M; Gaya A; Torrebadell M; Fernández-Avilés F; Aymerich M; Marín P; Sierra J; Montserrat E
Haematologica; 2007 Dec; 92(12):1655-63. PubMed ID: 18055989
[TBL] [Abstract][Full Text] [Related]
18. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
Gil L; Styczynski J; Komarnicki M
Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
[TBL] [Abstract][Full Text] [Related]
19. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]